Sale!

ERCC6 Gene Cerebrooculofacioskeletal Syndrome Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ERCC6 gene cerebrooculofacioskeletal syndrome type 1 genetic test is a sophisticated diagnostic tool designed to identify mutations in the ERCC6 gene, which are responsible for cerebrooculofacioskeletal syndrome type 1 (COFS1). COFS1 is a rare genetic disorder characterized by developmental delays, microcephaly, impaired facial features, and other systemic abnormalities, affecting the brain, eyes, and skeletal system. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.

The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory setting to detect any genetic abnormalities in the ERCC6 gene. This detailed analysis helps in confirming the diagnosis of COFS1, enabling healthcare providers to devise a tailored management plan for the patient.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the ERCC6 gene cerebrooculofacioskeletal syndrome type 1 genetic test is 4400 AED, reflecting the sophisticated technology and expertise required to conduct such specialized genetic testing. This investment is pivotal for affected families seeking answers and a clear direction for the care and support of their loved ones with COFS1.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ERCC6 Gene Cerebrooculofacioskeletal Syndrome Type 1 Genetic Test

At DNA Labs UAE, we offer the ERCC6 Gene Cerebrooculofacioskeletal Syndrome Type 1 Genetic Test. This test helps diagnose and identify the genetic variations or mutations in the ERCC6 gene that may be responsible for the syndrome.

Test Details

The ERCC6 gene is associated with a genetic disorder called cerebrooculofacioskeletal syndrome type 1 (COFS1). This syndrome is a rare autosomal recessive disorder characterized by a range of symptoms including intellectual disability, growth retardation, microcephaly (small head size), cataracts, skeletal abnormalities, and facial dysmorphism.

NGS (Next Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic variations or mutations that may be associated with a particular disorder. In the case of COFS1, NGS genetic testing can be used to identify mutations in the ERCC6 gene that may be responsible for the syndrome.

This type of genetic testing involves collecting a DNA sample, usually through a blood sample, and sequencing the DNA to analyze the entire coding region of the ERCC6 gene. Any mutations or variations found in the gene can then be compared to known disease-causing mutations to determine if they are responsible for the symptoms observed in the individual being tested.

Test Components and Price

  • Test Name: ERCC6 Gene Cerebrooculofacioskeletal Syndrome Type 1 Genetic Test
  • Components: NGS Technology
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Dysmorphology
  • Doctor: Pediatrics
  • Test Department: Genetics
  • Pre Test Information: Clinical History of Patient who is going for ERCC6 Gene Cerebrooculofacioskeletal Syndrome Type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERCC6 Gene Cerebrooculofacioskeletal Syndrome Type 1 NGS Genetic DNA Test gene ERCC6

Benefits of the Test

NGS genetic testing for COFS1 can help with the diagnosis of the syndrome, provide information about disease progression and management, and assist with genetic counseling for affected individuals and their families.

By identifying the specific mutations in the ERCC6 gene, this test can help healthcare professionals understand the underlying cause of the symptoms observed in the individual being tested. This information can then be used to develop appropriate treatment plans and provide accurate genetic counseling for affected individuals and their families.

At DNA Labs UAE, we understand the importance of accurate and reliable genetic testing. Our team of experts uses state-of-the-art NGS technology to ensure the highest quality results. With a report delivery time of 3 to 4 weeks, we strive to provide timely and comprehensive genetic testing services.

For more information or to schedule an appointment for the ERCC6 Gene Cerebrooculofacioskeletal Syndrome Type 1 Genetic Test, please contact us.

Test Name ERCC6 Gene Cerebrooculofacioskeletal syndrome type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ERCC6 Gene Cerebrooculofacioskeletal syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERCC6 Gene Cerebrooculofacioskeletal syndrome type 1 NGS Genetic DNA Test gene ERCC6
Test Details

The ERCC6 gene is associated with a genetic disorder called cerebrooculofacioskeletal syndrome type 1 (COFS1). This syndrome is a rare autosomal recessive disorder characterized by a range of symptoms including intellectual disability, growth retardation, microcephaly (small head size), cataracts, skeletal abnormalities, and facial dysmorphism.

NGS (Next Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the detection of genetic variations or mutations that may be associated with a particular disorder. In the case of COFS1, NGS genetic testing can be used to identify mutations in the ERCC6 gene that may be responsible for the syndrome.

This type of genetic testing involves collecting a DNA sample, usually through a blood sample, and sequencing the DNA to analyze the entire coding region of the ERCC6 gene. Any mutations or variations found in the gene can then be compared to known disease-causing mutations to determine if they are responsible for the symptoms observed in the individual being tested.

NGS genetic testing for COFS1 can help with the diagnosis of the syndrome, provide information about disease progression and management, and assist with genetic counseling for affected individuals and their families.